NCT00386984View on ClinicalTrials.gov

Hector-Study to Evaluate the Efficacy of Octreotide in Patients With Inoperable Hepatocellular Carcinoma

PHASE3CompletedINTERVENTIONAL

Enrollment

108

Participants

Timeline

Start Date

October 31, 1999

Study Completion Date

February 28, 2003

Conditions

Carcinoma, Hepatocellular

Interventions

DRUG

Somatostatin (octreotide)

Trial Locations (1)

79106

University Medical Center Freiburg, Freiburg im Breisgau

Sponsors

Collaborators (1)

All Listed Sponsors

collaborator

German Federal Ministry of Education and Research

OTHER_GOV

collaborator

Deutsche Krebshilfe e.V., Bonn (Germany)

OTHER

collaborator

Novartis

INDUSTRY

lead

University Hospital Freiburg

OTHER